Research Theme
Theme Leads
Theme Members - Secondary
Prof CHEN Xiaoyuan, Shawn
Primary research focus is on molecular imaging for precise targeted cancer therapy. He has developed a series of novel translational theranostic agents, some of which have obtained clinical approval and are currently being evaluated in clinical trials.
Prof Chen also researches on the systematic investigation and application of translational nanotherapeutics in cancer immunotherapy. He has developed a series of nanotherapeutic systems for the early diagnosis, precise treatment, and effective monitoring of various malignancies, including prostate cancer, pancreatic cancer, colorectal cancer, and so on.
Dr Le Thi Nguyet MINH
Research focus is on biology and engineering of extracellular vesicles for therapeutics.
A/Prof Michelle POON
Research focus is on hematopoietic stem cell transplantation and cellular therapy.
Dr TOH Tan Boon
Our lab focuses on advancing functional precision and personalised oncology by developing patient-derived models that accurately reflect the molecular andcellular complexity of human cancers. Additionally, our research investigates the clinically relevant mechanisms of drug resistance in these models to enhance therapeutic effectiveness.
Dr TOH Tan Boon
Our lab focuses on advancing functional precision and personalised oncology by developing patient-derived models that accurately reflect the molecular andcellular complexity of human cancers. Additionally, our research investigates the clinically relevant mechanisms of drug resistance in these models to enhance therapeutic effectiveness.
Theme Members - Adjunct
Dr KONG Li Ren
Dr TOH Tan Boon
Our lab focuses on advancing functional precision and personalised oncology by developing patient-derived models that accurately reflect the molecular andcellular complexity of human cancers. Additionally, our research investigates the clinically relevant mechanisms of drug resistance in these models to enhance therapeutic effectiveness.
Dr TOH Tan Boon
Our lab focuses on advancing functional precision and personalised oncology by developing patient-derived models that accurately reflect the molecular andcellular complexity of human cancers. Additionally, our research investigates the clinically relevant mechanisms of drug resistance in these models to enhance therapeutic effectiveness.